Chen Yi-No, Zhou Junlan, Kirkham Heather S, Witt Edward A, Jenness Samuel M, Wall Kristin M, Kamaleswaran Rishi, Naimi Ashley I, Siegler Aaron J
Department of Epidemiology, Emory University, Atlanta, Georgia, USA.
Health Analytics, Research, and Reporting Department, Walgreen Co., Deerfield, Illinois, USA.
Open Forum Infect Dis. 2024 Oct 11;11(11):ofae584. doi: 10.1093/ofid/ofae584. eCollection 2024 Nov.
Understanding longitudinal patterns of preexposure prophylaxis (PrEP) use among men who have sex with men could offer insights for developing efficient and timely interventions to promote PrEP persistence.
We extracted 2 years of pharmacy fill records for 4000 males who initiated PrEP in 2017 at a national chain pharmacy in the United States.
Group-based trajectory models were used to develop PrEP trajectory clusters, with periods of use defined based on optimal PrEP seroprotection probabilities (ie, PrEP use frequency ≥4 doses/week). Multinomial logistic regressions were used to evaluate the associations between sociodemographic covariates and identified trajectory group membership.
We identified 4 distinct groups of PrEP persistence trajectories: (1) persistent use of PrEP throughout the period (persistent user), (2) brief use followed by sustained cessation of PrEP use (brief user), (3) PrEP use up to the mid-term followed by sustained cessation of PrEP use (mid-term user), and (4) PrEP use, followed by cessation and subsequent reinitiation (PrEP reinitiator). Persistent users and brief users accounted for 40.1% and 22.9% of the population, respectively, whereas mid-term users and reinitiators accounted for 18.9% and 18.2%, respectively. Older age at PrEP initiation, commercial insurance as the primary payer of PrEP, and use of specialty pharmacy were found to be associated with persistent PrEP use over the other patterns of nonpersistence.
Subgroups of PrEP users could benefit from PrEP persistence interventions that target specific timings of likely PrEP cessation or considerations of reinitiation.
了解男男性行为者中暴露前预防(PrEP)的长期使用模式,可为制定高效及时的干预措施以促进PrEP持续使用提供见解。
我们提取了2017年在美国一家全国连锁药店开始使用PrEP的4000名男性的两年药房配药记录。
基于群体的轨迹模型用于确定PrEP轨迹集群,使用期限根据最佳PrEP血清保护概率定义(即PrEP使用频率≥4剂/周)。多项逻辑回归用于评估社会人口统计学协变量与确定的轨迹组成员之间的关联。
我们确定了4种不同的PrEP持续使用轨迹组:(1)在整个期间持续使用PrEP(持续使用者),(2)短暂使用后持续停止使用PrEP(短暂使用者),(3)PrEP使用至中期后持续停止使用PrEP(中期使用者),以及(4)PrEP使用、停止使用随后重新开始使用(PrEP重新开始使用者)。持续使用者和短暂使用者分别占人群的40.1%和22.9%,而中期使用者和重新开始使用者分别占18.9%和18.2%。PrEP开始使用时年龄较大、商业保险作为PrEP的主要支付方以及使用专科药房被发现与其他非持续使用模式相比,与PrEP的持续使用相关。
PrEP使用者亚组可从针对可能停止使用PrEP的特定时间或重新开始使用的考虑因素的PrEP持续使用干预措施中受益。